−0.14USD
−25.09 MUSD
116.88 MUSD
171.94 M
About Rigel Pharmaceuticals, Inc.
Sector
CEO
Raul R. Rodriguez
Headquarters
South San Francisco
Website
Employees (FY)
147
Founded
1996
ISIN
US7665596034
FIGI
BBG000BPWTW7
Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of RIGL is 1.14 USD — it has decreased by 0.87% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Rigel Pharmaceuticals, Inc. stocks are traded under the ticker RIGL.
Rigel Pharmaceuticals, Inc. is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Rigel Pharmaceuticals, Inc. has a max estimate of 15.00 USD and a min estimate of 1.65 USD.
RIGL earnings for the last quarter are −0.03 USD whereas the estimation was −0.07 USD which accounts for 57.74% surprise. Estimated earnings for the next quarter are −0.02 USD. See more details about Rigel Pharmaceuticals, Inc. earnings.
Rigel Pharmaceuticals, Inc. revenue for the last quarter amounts to 28.13 M USD despite the estimated figure of 27.20 M USD. In the next quarter revenue is expected to reach 34.10 M USD.
Yes, you can track Rigel Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, RIGL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Rigel Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 147.00 employees. See our rating of the largest employees — is Rigel Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Rigel Pharmaceuticals, Inc. EBITDA is −19.25 M USD, and current EBITDA margin is −16.47%. See more stats in Rigel Pharmaceuticals, Inc. financial statements.